We hypothesized that pentamidine curbs the ability of the cancer cells to destroy T cells by binding with PD-L1 expressed by humanized murine tumor cells, thereby allowing T cells to infiltrate the tumor and initiate an anti-tumor immune response. The gene discussed is CD274; the disease is neoplasm.